Not applicableStudy completedNCT01528774What this trial is testingCulture and Characterization of Circulating Tumor Cells (CTC) in Melanoma and Other CancersWho this might be right forMelanoma Wolfram Samlowski 150
Large-scale testing (Phase 3)Study completedNCT00672282What this trial is testingCasodex vs Placebo in Non-Metastatic Early Prostate CancerWho this might be right forNon-Metastatic Prostate Cancer AstraZeneca 1,218
Not applicableStudy completedNCT02729103What this trial is testingTreatment Patterns in Metastatic Prostate CancerWho this might be right forProstatic Neoplasm Bayer 565
Testing effectiveness (Phase 2)Study completedNCT03655886What this trial is testingCytoreductive Prostatectomy Versus Cytoreductive Prostate Irradiation As a Local Treatment Option for Metastatic Prostate Cancer: a Multicentric Feasibility TrialWho this might be right forProstate Cancer Metastatic University Hospital, Ghent 43
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07723651What this trial is testing[18F]Fluorthanatrace - Positron Emission Tomography (FTT-PET) and ctDNA to Predict Response to PARP Inhibitor Therapy in Metastatic Prostate Cancer (mPC)Who this might be right forMetastatic Prostate CancerProstate Cancer Washington University School of Medicine 75
Large-scale testing (Phase 3)Study completedNCT00869206What this trial is testingZoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone InvolvementWho this might be right forBreast AdenocarcinomaDS Stage I Plasma Cell MyelomaDS Stage II Plasma Cell Myeloma+4 more Alliance for Clinical Trials in Oncology 1,822
Not applicableLooking for participantsNCT05761093What this trial is testingPatient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice ExperimentWho this might be right forProstate Cancer Chinese University of Hong Kong 306
Very early researchEnded earlyNCT01724619What this trial is testingUpdate and Biodistribution of [F-18]FMDHT pET/CT in Normal Healthy Volunteers and Patients With Metastatic Prostate Cancer - A First in Human Subject Study With [F-18] FMDHTWho this might be right forProstate Cancer Wake Forest University Health Sciences 7
Testing effectiveness (Phase 2)Study completedNCT00659438What this trial is testingEfficacy and Safety of Zactima™ in Patients With Castration-refractory Metastatic Prostate CancerWho this might be right forProstate Cancer Genzyme, a Sanofi Company 95
Post-approval studies (Phase 4)Study completedNCT00172016What this trial is testingEvaluate the Efficacy and Tolerability of Zoledronic Acid in Patients With Metastatic Prostate Cancer Who Can be Treated With a Group of Medications Known as BisphosphonatesWho this might be right forProstate Cancer With at Least One Bone Lesion in Patients Receiving Hormonal Therapy and Treatment With Bisphosphonates is Indicated Novartis Pharmaceuticals 43
Testing effectiveness (Phase 2)Study completedNCT01487720What this trial is testingGEMOX in Docetaxel-Refractory Castration-Resistant Prostate CancerWho this might be right forProstate Cancer Asan Medical Center 33
Not applicableLooking for participantsNCT07572760What this trial is testingLow to Moderate Load Power Training for Men With Metastatic Prostate Cancer.Who this might be right forProstatic Neoplasms University of Alicante 66
Testing effectiveness (Phase 2)Study completedNCT01254513What this trial is testingFeasibility of a Chemotherapy With Docetaxel-Prednisone for Castration-resistant Metastatic Prostate Cancer Elderly PatientsWho this might be right forProstate Cancer UNICANCER 66
Testing effectiveness (Phase 2)Ended earlyNCT00003533What this trial is testingAntineoplaston Therapy in Treating Patients With Metastatic Prostate CancerWho this might be right forMetastatic Prostate Cancer Burzynski Research Institute 12
Not applicableActive Not RecruitingNCT04030338What this trial is testingProstate-Specific Membrane Antigen (PSMA) PET Scans in People Prostate CancerWho this might be right forProstate CancerProstate NeoplasmProstate Adenocarcinoma+2 more Memorial Sloan Kettering Cancer Center 58
Testing effectiveness (Phase 2)Study completedNCT02962284What this trial is testingOne-year, Open Extension to Evaluate the Treatment of Patients With Castration-Resistant Prostate Cancer With YONSA™Who this might be right forMetastatic Prostate Cancer Sun Pharmaceutical Industries Limited 20
Testing effectiveness (Phase 2)Study completedNCT00003238What this trial is testingPerillyl Alcohol in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone TherapyWho this might be right forProstate Cancer University of Wisconsin, Madison
Large-scale testing (Phase 3)Active Not RecruitingNCT04455750What this trial is testingA Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With Metastatic Prostate Cancer That Has Become Resistant To Testosterone-Deprivation TherapyWho this might be right forCastration-Resistant Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IV Prostate Cancer AJCC v8+2 more Alliance for Clinical Trials in Oncology 61
Testing effectiveness (Phase 2)Ended earlyNCT01119118What this trial is testingZD4054 With Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) for Prostate CancerWho this might be right forProstate Cancer University of Wisconsin, Madison 6
Large-scale testing (Phase 3)Study completedNCT00089674What this trial is testingAMG 162 in the Treatment of Bone Loss in Subjects Undergoing Androgen-Deprivation Therapy for Non-metastatic Prostate CancerWho this might be right forProstate Cancer Amgen 1,468